Introduction to Biological and Small Molecule Drug Research and Development: Chapter 12. Hormone replacement therapy
- ISBN-10
- 0128062029
- ISBN-13
- 9780128062029
- Series
- Introduction to Biological and Small Molecule Drug Research and Development
- Category
- Science
- Pages
- 472
- Language
- English
- Published
- 2013-05-07
- Publisher
- Elsevier Inc. Chapters
- Author
- Stanley M. Roberts
Description
Menopause affects the quality of life for women, sometimes severely. The symptoms can be addressed by treatment with steroids, namely, an oestrogen alone or an oestrogen with a progestin. The treatment is called hormone replacement therapy (HRT). However, for years, HRT has been associated with side effects, for instance, an increased risk of breast or endometrial cancer and stroke. The potentially positive effect of reducing some forms of heart disease is still a matter of debate, while the HRT-related decrease in bone fracture/osteoporosis is more certain. The rise, fall and current status of HRT is summarized in this chapter.
Get the book
Other editions
-
- 2013-05-07
- 472 pages
- Ebook
- Elsevier Inc. Chapters
-
- 2013-05-07
- 472 pages
- Ebook
- Elsevier Inc. Chapters
-
- 2013-05-07
- 472 pages
- Ebook
- Elsevier Inc. Chapters
-
- 2013-05-07
- 472 pages
- Ebook
- Elsevier Inc. Chapters
Similar books
-
Introduction to Biological and Small Molecule Drug Research and Development: Theory and Case Studies
By Stanley M. Roberts, C. Robin Ganellin, Roy JefferisThe book explains basic principles, then compares and contrasts approaches to both biopharmaceuticals (proteins) and small molecule drugs, presenting an overview of the business and management issues of these approaches.
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 7. The structure and business of biopharmaceutical companies including...
By James SamanenSuccessful drugs have a good return on investment by bringing in considerably more revenue than the expenses of discovery, development, and manufacturing.
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 11. Lysosomal storage disorders: current treatments and future directions
By Charles W. RichardLysosomal storage disorders (LSDs) represent a group of about 50 genetic disorders caused by deficiencies of lysosomal proteins.
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 9. Targeting HER2 by monoclonal antibodies for cancer therapy
By null HasmannHER2 (ErbB-2) is a member of the human epidermal growth factor receptor tyrosine kinase family which is involved in the regulation of cell proliferation, survival and differentiation.
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 10. Recombinant human erythropoietin and its analogues
By Wolfgang JelkmannThe renal hormone erythropoietin (Epo) is essential for the viability and proliferation of the erythrocytic progenitors generating reticulocytes in the bone marrow.
-
Small Molecule Drug Discovery: Methods, Molecules and Applications
By Andrea Trabocchi, Elena LenciThe second part of the book gives an overview of privileged cyclic small molecules and major classes of natural product-derived small molecules, including carbohydrate-derived compounds, peptides and peptidomimetics, and alkaloid-inspired ...
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 6. Therapies for type 2 diabetes: modulating the incretin...
By David Fairman, Matthew P. CoghlanMoreover, data from preclinical rodent disease models and isolated human pancreatic islets suggested that these novel agents could preserve pancreatic β-cell function and thus impede disease progression.
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 15. Discovery of the cholesterol absorption inhibitor, ezetimibe
By C. Robin GanellinA brief introduction to cholesterol and lipoproteins is followed by a short account of the types of drugs which reduce cholesterol levels (bile sequestrants, hypocholesterolaemics, fibrates as acyl-CoA:cholesterol acyltransferase (ACAT) ...
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 13. Design of the anti-HIV protease inhibitor darunavir
By Arun K. Ghosh, Bruno D. ChapsalThe development of HIV protease inhibitors (PIs) and their inclusion in highly active antiretroviral therapies (HAARTs) marked the beginning of a treatment breakthrough in the management of human immunodeficiency virus (HIV)/acquired ...
-
Introduction to Biological and Small Molecule Drug Research and Development: Chapter 14. The case of anti-TNF agents
By Denis Mulleman, Marc Ohresser, Hervé WatierParallel studies in septic shock and cancer led to the discovery of the endogenous factors named cachectin and tumour necrosis factor (TNF), respectively, that were shown to be structurally and functionally similar.